We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Voya Financial
VOYA
$9.29B
| $952K | ﹤0.01% |
13,407
+1,254
| +10% | +$80.5K |
|
1152
Intel
INTC
$473B
| $950K | ﹤0.01% |
42,411
-123,827
| -74% | -$2.57M |
|
1153
Jabil
JBL
$31.6B
| $939K | ﹤0.01% |
4,306
-35,250
| -89% | -$5.71M |
|
1154
SEI Investments
SEIC
$13.4B
| $936K | ﹤0.01% |
10,420
-434
| -4% | -$35K |
|
1155
Western Alliance Bancorporation
WAL
$8.57B
| $936K | ﹤0.01% |
12,002
-38
| -0.3% | -$2.73K |
|
|
THS
1156
DELISTED
Treehouse Foods
THS
| $934K | ﹤0.01% |
48,120
-1,965
| -4% | -$44K |
|
1157
Coca-Cola Consolidated
COKE
$13.2B
| $931K | ﹤0.01% |
8,343
-27
| -0.3% | -$3.26K |
|
1158
Penumbra
PEN
$12.7B
| $928K | ﹤0.01% |
3,615
-19
| -0.5% | -$5.17K |
|
1159
GameStop
GME
$8.02B
| $927K | ﹤0.01% |
38,013
-487
| -1% | -$13.1K |
|
1160
Valmont Industries
VMI
$9.19B
| $927K | ﹤0.01% |
2,838
+539
| +23% | +$165K |
|
1161
Fulgent Genetics
FLGT
$540M
| $924K | ﹤0.01% |
46,479
| – | – |
|
1162
Goodyear
GT
$1.83B
| $921K | ﹤0.01% |
88,787
-22,239
| -20% | -$235K |
|
1163
Cabot Corp
CBT
$4.32B
| $912K | ﹤0.01% |
12,159
-719
| -6% | -$55K |
|
1164
Kodiak Sciences
KOD
$2.37B
| $911K | ﹤0.01% |
244,231
+160,225
| +191% | +$567K |
|
1165
Range Resources
RRC
$9.69B
| $907K | ﹤0.01% |
22,309
-541
| -2% | -$20.4K |
|
1166
Evercore
EVR
$11.2B
| $906K | ﹤0.01% |
3,356
+4
| +0.1% | +$880 |
|
1167
CubeSmart
CUBE
$9.01B
| $904K | ﹤0.01% |
21,280
-135
| -0.6% | -$5.6K |
|
1168
Houlihan Lokey
HLI
$9.3B
| $904K | ﹤0.01% |
5,021
-95
| -2% | -$16K |
|
1169
Regal Rexnord
RRX
$10.5B
| $898K | ﹤0.01% |
6,193
-78
| -1% | -$9.78K |
|
1170
A10 Networks
ATEN
$1.87B
| $891K | ﹤0.01% |
46,022
+534
| +1% | +$9.12K |
|
1171
Shoals Technologies Group
SHLS
$1.2B
| $885K | ﹤0.01% |
208,154
-1,578,853
| -88% | -$6.86M |
|
1172
Affiliated Managers Group
AMG
$9.59B
| $883K | ﹤0.01% |
4,490
-326
| -7% | -$56.6K |
|
1173
Edgewell Personal Care
EPC
$1.34B
| $883K | ﹤0.01% |
37,698
-12,201
| -24% | -$338K |
|
|
SFD
1174
Smithfield Foods
SFD
$8.64B
| $882K | ﹤0.01% |
37,500
-35,046
| -48% | -$775K |
|
1175
Axos Financial
AX
$5.55B
| $871K | ﹤0.01% |
11,456
+782
| +7% | +$52.9K |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.